What is JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares?
engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury.
ZJYL · Verdict
Limited reward · elevated risk
ZJYL has limited near-term tailwinds — volatility and profitability weigh on the model output.
Based on 88% data coverage
ZJYL · Verdict
Weak vs peers
6% net margin · 5% ROE
Weak vs peers
Rev +2.5% CAGR · earnings -23.9%
Net debt/EBITDA 12.3×
Model-based scoring. For information only — not financial advice.
engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs and other shared health products; oxygen chambers and beauty instruments; and shampoo instruments and nano thermal therapy chambers. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 22.71M, and a P/E ratio of 14.5x.
The scoring profile indicates weak reward characteristics across most factors, including momentum and size. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.